Skip to main content
. 2019 Oct 25;9:15362. doi: 10.1038/s41598-019-51724-6

Figure 3.

Figure 3

Virally mediated increases in cochlear NT3 expression, as assessed by qRT-PCR. (a) NT3 mRNA levels in injected and contralateral cochleas at post-injection days 1, 2.5, 5, 10, 21 and 40, normalized to mean levels in the contralateral ears. (b) To assess contralateral spread of the virus, NT3 mRNA levels were measured in both ears at 21 days post-injection and normalized to levels in uninjected controls. Histograms show means and SEMs; individual cases are shown by the colored circles in b.